TD Cowen Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $66.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective decreased by TD Cowen from $70.00 to $66.00 in a research report report published on Tuesday,Benzinga reports. TD Cowen currently has a buy rating on the stock.

A number of other equities analysts have also recently commented on the stock. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada lowered their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. Finally, KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target for the company in a research note on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $45.12 on Tuesday. The stock has a market cap of $4.19 billion, a P/E ratio of 14.79, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a fifty day moving average price of $40.48 and a two-hundred day moving average price of $58.19. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter last year, the company posted $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. Point72 Asset Management L.P. increased its position in Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after acquiring an additional 1,055,894 shares during the last quarter. Holocene Advisors LP boosted its holdings in shares of Acadia Healthcare by 201.5% during the 3rd quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after acquiring an additional 649,997 shares in the last quarter. Finally, William Blair Investment Management LLC grew its position in Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.